Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Total Assets Over TimeStrong
Percentile Rank86
3Y CAGR-0.3%
5Y CAGR-2.7%
Studio
Year-over-Year Change

Total value of everything the company owns

3Y CAGR
-0.3%/yr
vs +21.1%/yr prior
5Y CAGR
-2.7%/yr
Consistent
Acceleration
-21.3pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthStrong
PeriodValueYoY Change
2025$1.53B+1.9%
2024$1.50B+0.8%
2023$1.49B-3.5%
2022$1.55B+1.5%
2021$1.52B-13.5%
2020$1.76B+55.0%
2019$1.14B+57.8%
2018$719.56M+46.6%
2017$490.75M-9.2%
2016$540.63M-